Fides Pharma

Executive Summary

Fides Pharma is an early-stage Indian biotechnology company founded in 2020 and headquartered in Hyderabad. The company focuses on developing diagnostic tools, molecular biology kits, and research services across oncology, immunology, metabolic diseases, and neurology. With a platform-based business model and 10-50 employees, Fides Pharma leverages modern biotechnological approaches to address healthcare challenges, particularly in biomarker detection and molecular testing. As a private entity with no disclosed funding or valuation, the company is in a nascent stage and operates primarily in the Indian market, but its diversified therapeutic focus suggests potential for growth in diagnostics and research services.

Upcoming Catalysts (preview)

• TBDAnnouncement of strategic partnership or collaboration20% success
• TBDLaunch of new molecular diagnostics kit25% success
• TBDPublication of research results in peer-reviewed journal15% success